Sign in
4

Changes in Ownership

Disc Medicine, Inc. Filed Acc 0000950170-24-138086

Chief Executive Officer sold 12,791 shares at an average $66.01 ($844,314)

  • Chief Executive Officer acquired 12,791 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Quisel John D · Chief Executive Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2024-12-16 Exercise or conversion : show line 1 in the form 10b5-1 +12,791 $1.01 $12,919 84,856 D
2024-12-16 Sale : show line 2 in the form 10b5-1 −219 $64.66 $14,160 84,637 D
2024-12-16 Sale : show line 3 in the form 10b5-1 −5,767 $65.58 $378,194 78,870 D
2024-12-16 Sale : show line 4 in the form 10b5-1 −6,305 $66.35 $418,361 72,565 D
2024-12-16 Sale : show line 5 in the form 10b5-1 −500 $67.20 $33,599 72,065 D
Open-market sales · 12,791 sh · avg $66.01 · $844,314

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-12-16 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −12,791 225,420 D
Loading xslF345X05/ownership.xml…